Reply to Spek and Duitman.
作者信息
Oldham Justin M, Allen Richard J, Lorenzo-Salazar Jose M, Flores Carlos, Wain Louise V, Noth Imre
机构信息
Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan.
Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
出版信息
Am J Respir Crit Care Med. 2023 Jun 15;207(12):1644-1645. doi: 10.1164/rccm.202303-0402LE.
Abstract
摘要
相似文献
1
Reply to Spek and Duitman.对斯佩克和杜伊特曼的回复。
Am J Respir Crit Care Med. 2023 Jun 15;207(12):1644-1645. doi: 10.1164/rccm.202303-0402LE.
2
Reply to the letter by L.A. Hoogervorst, R. W.A. Spek and M. P.J. van den Bekerom.
Orthop Traumatol Surg Res. 2021 Jun;107(4):102921. doi: 10.1016/j.otsr.2021.102921. Epub 2021 Apr 6.
3
Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy.药理学 PAR-1 抑制可降低血糖水平，但不能改善实验性 2 型糖尿病肾病的肾功能。
FASEB J. 2019 Oct;33(10):10966-10972. doi: 10.1096/fj.201900516R. Epub 2019 Jul 9.
4
Semi-crystalline sulfonated poly(ether ketone) proton exchange membranes: The trade-off of facile synthesis and performance.半结晶磺化聚醚醚酮质子交换膜：易合成与性能之间的权衡。
J Colloid Interface Sci. 2023 Sep;645:493-501. doi: 10.1016/j.jcis.2023.04.116. Epub 2023 Apr 27.
5
Sulfonated Polyether Ketone Membranes Embedded with Nalidixic Acid-An Emerging Controlled Drug Releaser.嵌入萘啶酸的磺化聚醚酮膜——一种新型控释药物载体
Polymers (Basel). 2023 Sep 1;15(17):3631. doi: 10.3390/polym15173631.
6
Assessment of the Relationship between Clinical Manifestation and Pathogenic Potential of Strains-Distribution of Genes and Genotypes of Toxins.菌株临床表现与致病潜力之间关系的评估——毒素基因和基因型的分布
Biomedicines. 2022 Mar 29;10(4):799. doi: 10.3390/biomedicines10040799.
7
Screening babies' hearing: evaluating the Body Spek 2000.筛查婴儿听力：评估Body Spek 2000
Health Visit. 1986 Dec;59(12):377-8.
8
Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315.A群链球菌M3血清型菌株MGAS315中的前噬菌体诱导及前噬菌体编码的毒力因子表达
Infect Immun. 2003 Dec;71(12):7079-86. doi: 10.1128/IAI.71.12.7079-7086.2003.
9
2-Vinyl-pyridine-tris-(penta-fluoro-phen-yl)borane hexane monosolvate.2-乙烯基吡啶-三（五氟苯基）硼烷己烷单溶剂合物
Acta Crystallogr Sect E Struct Rep Online. 2012 Apr 1;68(Pt 4):o1261. doi: 10.1107/S1600536812013153. Epub 2012 Mar 31.
10
High-Performance Semicrystalline Poly(ether ketone)-Based Proton Exchange Membrane.高性能半晶态聚醚酮质子交换膜。
ACS Appl Mater Interfaces. 2017 Jul 26;9(29):24527-24537. doi: 10.1021/acsami.7b03720. Epub 2017 Jul 17.
本文引用的文献
1
PCSK6 and Survival in Idiopathic Pulmonary Fibrosis.载脂蛋白 C3 与特发性肺纤维化患者的生存。
Am J Respir Crit Care Med. 2023 Jun 1;207(11):1515-1524. doi: 10.1164/rccm.202205-0845OC.
2
Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition.联合 PAR（蛋白酶激活受体）-4 拮抗和因子 Xa 抑制的抗血栓作用。
Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2678-2685. doi: 10.1161/ATVBAHA.120.314960. Epub 2020 Sep 10.
3
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.医学指征地口服抗凝剂对特发性肺纤维化患者生存的不利影响。
Eur Respir J. 2016 Jun;47(6):1776-84. doi: 10.1183/13993003.02087-2015. Epub 2016 Apr 21.
4
Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder.神经炎症诱导的蛋白酶激活受体1与前蛋白转化酶在HIV相关神经认知障碍中的相互作用
Mol Cell Biol. 2015 Nov;35(21):3684-700. doi: 10.1128/MCB.00764-15. Epub 2015 Aug 17.
5
Reply: rationale for anticoagulant therapy of pulmonary fibrosis.回复：肺纤维化抗凝治疗的理论依据。
Am J Respir Crit Care Med. 2014 Feb 1;189(3):363. doi: 10.1164/rccm.201307-1328LE.
6
Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.靶向蛋白酶激活受体-1 用 P1pal-12 限制博来霉素诱导的肺纤维化。
Thorax. 2014 Feb;69(2):152-60. doi: 10.1136/thoraxjnl-2013-203877. Epub 2013 Sep 12.
7
Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.蛋白酶激活受体（PAR）-1 和 -3 驱动肺泡上皮细胞的上皮-间充质转化 - 在肺纤维化中的潜在作用。
Thromb Haemost. 2013 Aug;110(2):295-307. doi: 10.1160/TH12-11-0854. Epub 2013 Jun 6.
8
A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.华法林治疗特发性肺纤维化的安慰剂对照随机试验。
Am J Respir Crit Care Med. 2012 Jul 1;186(1):88-95. doi: 10.1164/rccm.201202-0314OC. Epub 2012 May 3.
Zotero 插件